Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bayer Ag Ord (OP: BAYZF ) 29.26 +0.61 (+2.12%) Streaming Delayed Price Updated: 1:20 PM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bayer Ag Ord < Previous 1 2 Next > Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B March 10, 2023 Bayer AG (OTC: BAYRY) intends to shell out around $1 billion on drug research and development in the U.S. in 2023 as it works to double its sales in the U.S. over the next ten years. Via Benzinga Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm January 18, 2023 Via Benzinga FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories January 11, 2023 Reuters Via Benzinga Activist Investor Builds Stake In Bayer, Pushes Breakup January 11, 2023 Activist investor Bluebell Capital Partners has built a stake in Bayer AG (OTC: BAYRY) (OTC: BAYZF) and is pushing it to split up. Via Benzinga Ionis Regains Rights To Thrombosis Candidate From Bayer November 04, 2022 Via Benzinga Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death August 29, 2022 Via Benzinga FDA Approves Expanded Use For Bayer's Prostate Cancer Drug August 08, 2022 Via Benzinga Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor October 05, 2022 Bayer AG (OTC: BAYRY) won five jury verdicts in a row in trials that contended its Roundup weed killer caused non-Hodgkin lymphoma. The company battles the remaining cases targeting its Roundup... Via Benzinga After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report September 14, 2022 Via Benzinga Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug September 08, 2022 Via Benzinga Morning Brief: Top Financial Stories Dominating on Friday, June 10 June 10, 2022 Reuters Rebranded McDonald’s Restaurants To Reopen In Russia Via Benzinga US Top Court To Decide On Bayer's Roundup Weedkiller Appeal June 10, 2022 Via Benzinga Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara May 20, 2022 Via Benzinga FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs April 21, 2022 The FDA aims to put the PI3K inhibitor drug class under a more stringent regulatory scope as the inhibitor has demonstrated substantial toxicity. Via Benzinga Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia March 15, 2022 Eli Lilly And Co (NYSE: LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines." Via Benzinga Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy March 15, 2022 Exelixis Inc (NASDAQ: EXEL) announced results from the final analysis of the second primary endpoint of overall survival (OS) from the phase 3 COSMIC-312 trial of Cabometyx (cabozantinib) plus... Via Benzinga Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities December 06, 2021 Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded... Via Benzinga Bayer's Nubeqa Shows Prolonged Survival In Late-Stage Prostate Cancer Trial December 03, 2021 Bayer AG (OTC: BAYRY) said a combination therapy, including its Nubeqa drug, was shown to prolong the lives of men who have metastatic prostate cancer in a clinical... Via Benzinga Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities November 17, 2021 Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries... Via Benzinga Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration August 24, 2021 Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related... Via Benzinga Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates August 11, 2021 Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed... Via Benzinga Topics Earnings Exposures Financial Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod July 21, 2021 The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo... Via Benzinga Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes July 12, 2021 The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid... Via Benzinga Exposures Product Safety Why Did Novocure Shares Plunge Today? July 01, 2021 Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer... Via Benzinga Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer June 28, 2021 Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (... Via Benzinga Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials June 08, 2021 Bayer AG’s (OTC: BAYRY) Parkinson’s disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative... Via Benzinga Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals June 03, 2021 Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline... Via Benzinga Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters May 27, 2021 A U.S. judge rejected Bayer AG’s (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that... Via Benzinga Exposures Glyphosate Artificial Intelligence Doctor App Ada Health Closes $90M Funding Led By Bayer, Samsung May 27, 2021 German digital health firm Ada Health has raised a $90 million funding round at an undisclosed valuation bringing total investment in the company up to around $150... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.